COBB STUART (Chief Scientific Officer) sold 24.6% of their position (6.80K shares) of NEUROGENE INC. on the open market
Open‑market sale worth $103.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/15/2025ACC: 0001404644-25-000046
Officer· Chief Scientific Officer
Since Feb 2026
-6.80K
Net shares
Net seller
$103.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.80K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.80K
Price / share
$15.15
Trade value
$103K
% of position
24.6%
5/14/2025
27.59K→20.79K
Total
Net shares
−6.80K
Net value
-$103K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/14/2025 | S · Sale | −6.80K | $15.15 | $103K | 24.6% | 27.59K | 20.79K |
| Total | −6.80K | -$103K | ||||||
Derivative Transactions0
No derivative transactions reported